- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 150 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- November 2024
- 100 Pages
Global
From €2181EUR$2,490USD£1,893GBP
- Report
- May 2024
- 136 Pages
Global
From €3502EUR$3,999USD£3,040GBP
Alcaftadine is a type of antihistamine used to treat allergies. It is a selective H1-receptor antagonist, meaning it blocks the action of histamine, a chemical released by the body during an allergic reaction. Alcaftadine is available in both over-the-counter and prescription forms, and is used to treat a variety of allergic conditions, including hay fever, hives, and itching. It is also used to treat eye allergies, such as conjunctivitis. Alcaftadine is generally well-tolerated, with few side effects.
The Alcaftadine market is a subset of the larger allergy drug market. It is a competitive market, with a variety of manufacturers offering different formulations of the drug. Alcaftadine is available in both generic and brand-name forms, and is widely available in pharmacies and online.
Some companies in the Alcaftadine market include Mylan, Sandoz, Teva Pharmaceuticals, and Perrigo. Show Less Read more